Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ReShape Lifesciences Inc. | obln-123116x10k.htm |
| EX-31.2 - EXHIBIT 31.2 - ReShape Lifesciences Inc. | obln123116ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - ReShape Lifesciences Inc. | obln123116ex311.htm |
| EX-23.1 - EXHIBIT 23.1 - ReShape Lifesciences Inc. | exhibit23.htm |
| EX-10.16 - EXHIBIT 10.16 - ReShape Lifesciences Inc. | obalon-3rdamendmenttolsaxe.htm |
| EX-10.13 - EXHIBIT 10.13 - ReShape Lifesciences Inc. | revisedobalondraftamendmen.htm |
| EX-10.8 - EXHIBIT 10.8 - ReShape Lifesciences Inc. | directoroptionagreement3.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Obalon Therapeutics, Inc. (the “Company”) for the fiscal year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Andrew Rasdal, the President and Chief Executive Officer, and William Plovanic, the Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 23, 2017
/s/ Andrew Rasdal | /s/ William Plovanic | |
Andrew Rasdal | William Plovanic | |
President and Chief Executive Officer (Principal Executive Officer) | Chief Financial Officer (Principal Financial Officer) | |
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.